Pediatric Epilepsy Study

• Status: Completed
• Trial end date: 2004-02-01

Summary

This study will evaluate the safety and effectiveness of oxcarbazepine (Trileptal) as monotherapy in the treatment of partial seizures in pediatric patients 1 month to 3 years of age.

• Phase: Phase 3

Details

• Lead Sponsor: Novartis Pharmaceuticals
• Treatments: Carbamazepine; Oxcarbazepine